Home > Quotes > MNTA

Momenta Pharmaceuticals, Inc. Common Stock Quote & Summary Data

MNTA 
$9.5
*  
0.18
1.93%
Get MNTA Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading MNTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MNTA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Momenta Pharmaceuticals, Inc. Common Stock Intraday Chart




News for MNTA

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 9.64 $ 25.56
Low $ 9.22 $ 7.86

The current last sale of $9.50 is 20.87% Higher thanthe 52 week low.

P/E Ratio

ETFs with MNTA as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0% BioShares Biotechnology Products Fund (BBP) -3.54 (-11.66%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a biotechnology company focused on developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease. Our approach to drug discovery and development is built around a complex systems analysis platform that we use to obtain a detailed understanding of complex chemical and biologic systems, design product candidates, evaluate the biological function of products and product candidates, and develop reliable and scalable manufacturing processes. The core objective of our platform is to resolve the complexity of molecular structures and related biologic systems. We first map the key measurements needed to obtain comprehensive data on a targeted molecular structure and related biology and then develop a set of analytic tools and methods, including standard, modified and proprietary analytics, to generate the data, including multiple related and complementary, or orthogonal, measures.  ... More ...  

Risk Grade

Where does MNTA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?